Plus therapeutics announces initiation of final cohort of respect™ glioblastoma trial

Data and safety monitoring board evaluated safety data in recommending cohort progression data and safety monitoring board evaluated safety data in recommending cohort progression

pstv Ratings Summary

pstv Quant Ranking